Delcath Sys Inc (NASDAQ:DCTH)

CAPS Rating: 1 out of 5

The Company is a development stage Company.

Results 1 - 20 of 25 : 1 2 Next »

Recs

1
Member Avatar Angus2010 (< 20) Submitted: 4/29/2013 7:15:10 PM : Outperform Start Price: $19.20 DCTH Score: -112.74

Will pass FDA..

Recs

0
Member Avatar glenisintn (< 20) Submitted: 3/11/2013 6:18:08 PM : Outperform Start Price: $34.56 DCTH Score: -119.40

This stock will continue to grow will the anticipation of FDA approval.

Recs

0
Member Avatar patelk2 (< 20) Submitted: 2/25/2013 10:33:58 PM : Outperform Start Price: $24.16 DCTH Score: -122.38

PDUFA-date of June 14th. Run-up expected in May-2013. Expect run-up to $3.5+

Recs

0
Member Avatar SamsaricSufferer (< 20) Submitted: 7/4/2012 7:42:42 PM : Outperform Start Price: $27.84 DCTH Score: -135.47

Technical play

Recs

1
Member Avatar originalslang (< 20) Submitted: 1/13/2012 11:01:47 AM : Outperform Start Price: $68.64 DCTH Score: -148.49

upside potential unlimited when product benefits so many people and company is beaten down by the large drug companies. Delcath will be bought out by bms or pfizer in the near future

Recs

0
Member Avatar jgittes (< 20) Submitted: 11/27/2011 2:29:34 AM : Outperform Start Price: $35.76 DCTH Score: -152.15

outperform

Recs

2
Member Avatar TDRH (99.68) Submitted: 3/29/2011 11:56:15 AM : Outperform Start Price: $112.16 DCTH Score: -145.65

Cannot remember who I was following on this pick.

Recs

1
Member Avatar solanZRaider (< 20) Submitted: 3/22/2011 6:42:47 PM : Outperform Start Price: $108.48 DCTH Score: -148.91

Mark4124NH

Recs

1
Member Avatar searleg (42.42) Submitted: 3/4/2011 1:50:33 PM : Outperform Start Price: $102.72 DCTH Score: -145.69

The PHP system they are developing will pass FDA approval and become the standard of care for organ chemotherapy treatment.

Recs

1
Member Avatar ryansal (< 20) Submitted: 2/27/2011 11:52:17 AM : Outperform Start Price: $101.12 DCTH Score: -144.38

DCTH has a lot of cash for a development stage company. And unlike the run up in december to almost $12 per the NDA , this year they have exposure in Europe... could we then see a run up to $15-$16 before the next NDA in Sept 2011?? Something to think about...

Recs

0
Member Avatar Andreavich (< 20) Submitted: 2/23/2011 5:28:44 PM : Outperform Start Price: $100.16 DCTH Score: -146.53

Because the FDA did not squash the product but has unresolved questions about it that require clarification.

Recs

0
Member Avatar gstroube (44.34) Submitted: 2/20/2011 12:43:44 PM : Outperform Start Price: $110.40 DCTH Score: -144.20

Great tecnology

Recs

0
Member Avatar Mark4124NH (< 20) Submitted: 2/4/2011 10:06:17 PM : Outperform Start Price: $172.16 DCTH Score: -146.63

DCTH is awaiting NDA from the FDA. It has begun to run as a result and its chart looks extremely positive technically. They just disclosed a 5.08% Blackrock stake in FDA 13g filing. And if the CEO is correct with his believe of 15b market potential, this stock is worth many times its current value.

Recs

0
Member Avatar Crucible151 (< 20) Submitted: 1/1/2011 1:59:01 PM : Outperform Start Price: $157.92 DCTH Score: -152.05

FDA approval very optimistic.

Recs

0
Member Avatar dtannen (< 20) Submitted: 10/26/2010 6:27:48 PM : Outperform Start Price: $139.20 DCTH Score: -163.36

Delcath should get approval for melanoma mid-2011. The opportunity is much bigger for its PHP system though.

Recs

0
Member Avatar pjrmis (< 20) Submitted: 10/22/2010 11:49:12 AM : Outperform Start Price: $132.96 DCTH Score: -162.91

This is really a no brainer when you get past all of the rhetoric. They built a system that puts Chemo only into the organ/region with cancer instead of poisoning the whole patient.

Once approved by the FDA in 2011 I predict a $50 share price.

Recs

1
Member Avatar syazic (55.28) Submitted: 9/10/2010 12:32:38 PM : Outperform Start Price: $102.56 DCTH Score: -172.85

bottom

Recs

1
Member Avatar jimswarthout (< 20) Submitted: 8/6/2010 9:44:01 AM : Outperform Start Price: $125.60 DCTH Score: -171.27

Unique drug delivery system

Recs

1
Member Avatar tgretethan (< 20) Submitted: 6/26/2010 6:18:54 AM : Outperform Start Price: $126.24 DCTH Score: -178.26

Significant phase III results, high short interest will cause this to pop going into FDA approval

Recs

1
Member Avatar 1880gh (< 20) Submitted: 4/27/2010 3:46:58 PM : Outperform Start Price: $237.92 DCTH Score: -163.13

great invetion give people a little more life mikeeee

Results 1 - 20 of 25 : 1 2 Next »

Featured Broker Partners


Advertisement